BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 17986787)

  • 1. Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors.
    Zhong X; Deng H; Long M; Yin H; Zhong Q; Zheng S; Gong T; He L; Wang G; Sun Q
    Bioorg Chem; 2023 Sep; 138():106597. PubMed ID: 37245245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer.
    Chen Z; Wang M; Wu D; Zhao L; Metwally H; Jiang W; Wang Y; Bai L; McEachern D; Luo J; Wang M; Li Q; Matvekas A; Wen B; Sun D; Chinnaiyan AM; Wang S
    J Med Chem; 2024 Apr; 67(7):5351-5372. PubMed ID: 38530938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer.
    Luo J; Chen Z; Qiao Y; Ching-Yi Tien J; Young E; Mannan R; Mahapatra S; He T; Eyunni S; Zhang Y; Zheng Y; Su F; Cao X; Wang R; Cheng Y; Seri R; George J; Shahine M; Miner SJ; Vaishampayan U; Wang M; Wang S; Parolia A; Chinnaiyan AM
    bioRxiv; 2024 Mar; ():. PubMed ID: 38586029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.
    Jaiswal B; Agarwal A; Gupta A
    Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
    Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
    Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic diet: impact on the epigenome and cancer.
    Hardy TM; Tollefsbol TO
    Epigenomics; 2011 Aug; 3(4):503-18. PubMed ID: 22022340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes induced by curcumin and other natural compounds.
    Reuter S; Gupta SC; Park B; Goel A; Aggarwal BB
    Genes Nutr; 2011 May; 6(2):93-108. PubMed ID: 21516481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone acetyl transferases as emerging drug targets.
    Dekker FJ; Haisma HJ
    Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current development of CBP/p300 inhibitors in the last decade.
    He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
    Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth.
    Lee YH; Hong SW; Jun W; Cho HY; Kim HC; Jung MG; Wong J; Kim HI; Kim CH; Yoon HG
    Biosci Biotechnol Biochem; 2007 Nov; 71(11):2712-9. PubMed ID: 17986787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J; Zhu J; Goodman OB; Pestell RG; Schlegel PN; Nanus DM; Shen R
    Oncogene; 2006 Mar; 25(14):2011-21. PubMed ID: 16434977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anti-histone acetyltransferase activity from Rosa rugosa Thunb. (Rosaceae) extracts on androgen receptor-mediated transcriptional regulation.
    Lee YH; Jung MG; Kang HB; Choi KC; Haam S; Jun W; Kim YJ; Cho HY; Yoon HG
    J Ethnopharmacol; 2008 Aug; 118(3):412-7. PubMed ID: 18562138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
    Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
    Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity.
    Lee YH; Kwak J; Choi HK; Choi KC; Kim S; Lee J; Jun W; Park HJ; Yoon HG
    Int J Mol Med; 2012 Jul; 30(1):69-74. PubMed ID: 22505206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grape seed extract regulates androgen receptor-mediated transcription in prostate cancer cells through potent anti-histone acetyltransferase activity.
    Park SY; Lee YH; Choi KC; Seong AR; Choi HK; Lee OH; Hwang HJ; Yoon HG
    J Med Food; 2011; 14(1-2):9-16. PubMed ID: 21244239
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.